Selective iGluR5 receptor antagonists

Details Selective iGluR5 receptor antagonists Selective iGluR5 receptor antagonists

2005-02-15

2005-02-15

Davis, Zinna Northington (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

06855823

ABSTRACT:
The present invention provides a method of treating or preventing migraine comprising administering to a patient in need thereof an effective amount of a selective iGluR5receptor antagonist. The present invention further provides novel compounds functional as selective iGluR5receptor antagonists as well as compositions and formulations comprising said selective iGluR5receptor antagonists.

REFERENCES:
patent: 5356902 (1994-10-01), Ornstein
patent: 5446051 (1995-08-01), Ornstein
patent: 5670516 (1997-09-01), Arnold et al.
patent: 5767117 (1998-06-01), Moskowitz
patent: WO 9845270 (1998-10-01), None
patent: WO 0102367 (2001-01-01), None
Procter, et al., “Possible role of GluR5 glutamate receptors in spinal nociceptive processing in the anaesthetized rat,”Journal of Physiology, 504, pp. 101P-102P (1997).
Nikam, et al., “The search for AMPA/Gly (N) receptor antagonists,”Drugs of the Future, 24(10), pp. 1107-1124 (1999).
O'Neill, MJ, et al., “Decahydroisoquinolines: Novel competitive AMPA/kainite antagonists with neuroprotective effects in global cerebral ischaemia,”Neuropharmacology, 37, pp. 1211-1222 (1998).
Proctor, MJ, et al., “Actions of kainite and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cord,”Neuropharmacology, 37, pp. 1287-1297 (1998).
Bleakman, D., “Kainate receptor pharmacology and physiology,”Cellular and Molecular Life Sciences, 56/7-8, pp. 558-556 (1999).
Simmons, RM, et al., “Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat,”Neuropharmacology, 37(1), pp. 25-36 (1998).
National Library of Medicine (NLM), Bethesda, MD, US: Mitsilostas, DD, et al., “Non-NMDA glutamate receptors modulate capsaicin induced c-fos expression within trigeminal nucleus caudalis,”Database accession No. 100003939&British Journal of Pharmacology, 127(3), pp. 623-630 (1999).
Sahara, Y, et al., “Glutamate receptor subunits GluR5 and KA-2 are coexpressed in rat trigeminal ganglion neurons,”The Journal of Neuroscience, 17(17), pp. 6611-6620 (1997).
Alam, A., et al., “Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache,”Journal of Neurological Sciences, 156, pp. 102-106 (1998).

Affiliated with

Also associated with

Rating

Selective iGluR5 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selective iGluR5 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective iGluR5 receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3503122